PIRPath: A region-guided weakly supervised pathomics framework for neoadjuvant immunotherapy response prediction across multiple cancer types

Translational Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles